-
公开(公告)号:US20200048606A1
公开(公告)日:2020-02-13
申请号:US16455118
申请日:2019-06-27
Inventor: Alexander Marson , Gregory G. Lavieu , Annamaria Mocciaro , Theodore L. Roth , Magali Soumillon , Hayley M. Bennett
IPC: C12N5/0783 , B01L3/00 , C12N15/10
Abstract: Methods are described herein for isolating clonal populations of T cells having a defined genetic modification. The methods are performed, at least in part, in a microfluidic device comprising one or more sequestration pens. The methods include the steps of: maintaining individual T cells (or precursors thereof) that have undergone a genomic editing process in corresponding sequestration pens of a microfluidic device; expanding the T cells into respective clonal populations of T cells; detecting, in one or more T cells of each clonal population, the absence of a cell surface marker that was present in the individual T cells (or precursors thereof); and detecting, in one or more T cells of each clonal population, the presence of a first nucleic acid sequence that is indicative of the presence of an on-target genome edit in the clonal population of T cells. Also described are compositions comprising one or more clonal populations of T cells isolated according to the methods disclosed herein.
-
公开(公告)号:US12234461B2
公开(公告)日:2025-02-25
申请号:US18463589
申请日:2023-09-08
Applicant: The Regents of the University of California
Inventor: Theodore Lee Roth , Alexander Marson
IPC: C12N15/113 , C12N9/22 , C12N15/10 , C12N15/90
Abstract: Provided herein are methods and compositions for editing the genome of a cell. In some embodiments, a nucleotide sequence of at least 200 nucleotides in length is inserted into a target region in the genome of a cell.
-
公开(公告)号:US20250041338A1
公开(公告)日:2025-02-06
申请号:US18710157
申请日:2022-11-17
Applicant: The Regents of the University of California , The J. David Gladstone Institutes, a testamentary trust established under the will of J. David
Inventor: Alexander Marson , Eric Shifrut , Julia Carnevale , Alan Ashworth
IPC: A61K35/17 , A61K39/00 , A61P35/00 , C12N5/0783 , C12N15/90
Abstract: Provided herein are genetically modified T cells that exhibit increased proliferation compared to wild-type T cells when stimulated, methods of generating such T cells, and methods of using the T cells for the treatment of a disease such as cancer.
-
公开(公告)号:US20250025576A1
公开(公告)日:2025-01-23
申请号:US18713033
申请日:2022-11-22
Applicant: The Regents of the University of California
Inventor: Ross C. Wilson , Dana V. Foss , John Hunsinger , Daniel Carr , Alexander Marson , David-Huy Nguyen , Srishti U. Sahu
Abstract: The present disclosure provides a cargo delivery fusion polypeptide comprising an endosomolytic polypeptide and a cell penetrating polypeptide; and compositions comprising the cargo delivery fusion polypeptide. The present disclosure also provides methods of delivering a cargo into a target eukaryotic cell, using a composition comprising an amphiphilic polypeptide.
-
公开(公告)号:US20240117360A1
公开(公告)日:2024-04-11
申请号:US18463589
申请日:2023-09-08
Applicant: The Regents of the University of California
Inventor: Theodore Lee Roth , Alexander Marson
IPC: C12N15/113 , C12N9/22 , C12N15/10 , C12N15/90
CPC classification number: C12N15/1138 , C12N9/22 , C12N15/102 , C12N15/90 , C12N2310/20 , C12N2320/53
Abstract: Provided herein are methods and compositions for editing the genome of a cell. In some embodiments, a nucleotide sequence of at least 200 nucleotides in length is inserted into a target region in the genome of a cell.
-
公开(公告)号:US20240115705A1
公开(公告)日:2024-04-11
申请号:US18274307
申请日:2022-02-04
Applicant: The J. Gladstone Institutes, a testamentary trust established under the will of J. David Gladstone , The Regents of the University of California
Inventor: Alexander Marson , Murad Mamedov
CPC classification number: A61K39/464429 , A61K39/4611 , A61K45/06 , A61P35/00 , C12N15/86 , G01N33/5011 , C12N2740/15043
Abstract: Described herein are positive and negative regulators of BTN3A, as well as methods for identifying subjects who can benefit from T cell therapies and/or various chemotherapies. The subjects can for example be suffering from immune disorders, cancer and other diseases and conditions.
-
公开(公告)号:US11814624B2
公开(公告)日:2023-11-14
申请号:US17498531
申请日:2021-10-11
Applicant: The Regents of the University of California
Inventor: Theodore Lee Roth , Alexander Marson
IPC: C12N15/113 , C12N15/10 , C12N15/90 , C12N9/22
CPC classification number: C12N15/1138 , C12N9/22 , C12N15/102 , C12N15/90 , C12N2310/20 , C12N2320/53
Abstract: Provided herein are methods and compositions for editing the genome of a cell. In some embodiments, a nucleotide sequence of at least 200 nucleotides in length is inserted into a target region in the genome of a cell.
-
公开(公告)号:US11590171B2
公开(公告)日:2023-02-28
申请号:US17725478
申请日:2022-04-20
Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor: Theodore Lee Roth , Eric Shifrut , Alexander Marson , Cristina Puig Saus , Antoni Ribas
IPC: A61K35/17 , C07K14/725 , C12N9/22 , C12N15/113 , C12N15/85 , C12N15/90
Abstract: Provided herein are methods and compositions for editing the genome of a human T cell. In some embodiments, a heterologous T cell receptor (TCR)-β chain and a heterologous TCR-α chain are inserted into exon 1 of a TCR subunit constant gene in the genome of the T cell.
-
公开(公告)号:US20210388362A1
公开(公告)日:2021-12-16
申请号:US17326252
申请日:2021-05-20
Applicant: The Regents of the University of California
Inventor: Theodore Lee Roth , Alexander Marson
IPC: C12N15/113 , C12N9/22 , C12N15/10 , C12N15/90
Abstract: Provided herein are methods and compositions for editing the genome of a cell. In some embodiments, a nucleotide sequence of at least 200 nucleotides in length is inserted into a target region in the genome of a cell.
-
公开(公告)号:US11033584B2
公开(公告)日:2021-06-15
申请号:US16568116
申请日:2019-09-11
Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor: Theodore Lee Roth , Eric Shifrut , Alexander Marson , Cristina Puig Saus , Antoni Ribas
IPC: A61K35/17 , C07K14/725 , C12N9/22 , C12N15/113 , C12N15/85 , C12N15/90
Abstract: Provided herein are methods and compositions for editing the genome of a human T cell. In some embodiments, a heterologous T cell receptor (TCR)-β chain and a heterologous TCR-α chain are inserted into exon 1 of a TCR subunit constant gene in the genome of the T cell.
-
-
-
-
-
-
-
-
-